Literature DB >> 23911334

Transplacentally transferred functional antibodies against Plasmodium falciparum decrease with age.

Patrick T Wilson1, Indu Malhotra, Peter Mungai, Christopher L King, Arlene E Dent.   

Abstract

Transplacental transfer of antibodies from clinically malaria immune pregnant women to their fetuses is thought to provide passive protection against malaria during infancy. However, the presences and duration of functional antibodies against Plasmodium falciparum (Pf) in newborns has not been described. We used growth inhibition assays (GIA) to measure total anti-malaria functional antibodies present at birth and over the following year. Samples were drawn from cord blood (n=86) and in infants at six and 12 months of life (n=86 and 65 respectively). Three laboratory Pf strains (D10, W2mef, 3D7) and a field isolate (Msambweni 2006) were used in the assays. Median (ranges) GIA levels for cord plasma differed between laboratory parasite strains: D10, 0% (0-81); W2mef, 6% (0-80); 3D7, 18% (0-88); Msambweni 2006, 6% (0-43) (P<0.001, Wilcoxon signed-rank test). GIA levels against all Pf strains were found to decline in infants from birth to six months (P<0.01, Wilcoxon, signed-rank test). Functional antibodies as measured by GIA are transferred to the fetus and wane in the infants over time. Infant protection from clinical malaria disease may in part be mediated by these functional anti-malaria antibodies.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Functional antibodies; Growth inhibition assay; Malaria; Plasmodium falciparum

Mesh:

Substances:

Year:  2013        PMID: 23911334      PMCID: PMC4136449          DOI: 10.1016/j.actatropica.2013.07.018

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  36 in total

1.  Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies.

Authors:  Kristina E M Persson; Chee T Lee; Kevin Marsh; James G Beeson
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

2.  Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination.

Authors:  Kazutoyo Miura; Hong Zhou; Samuel E Moretz; Ababacar Diouf; Mahamadou A Thera; Amagana Dolo; Ogobara Doumbo; Elissa Malkin; David Diemert; Louis H Miller; Gregory E D Mullen; Carole A Long
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

3.  Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways.

Authors:  Manoj T Duraisingh; Alexander G Maier; Tony Triglia; Alan F Cowman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

4.  A flow cytometry-based assay for measuring invasion of red blood cells by Plasmodium falciparum.

Authors:  Amy K Bei; Tiffany M Desimone; Aida S Badiane; Ambroise D Ahouidi; Tandakha Dieye; Daouda Ndiaye; Ousmane Sarr; Omar Ndir; Souleymane Mboup; Manoj T Duraisingh
Journal:  Am J Hematol       Date:  2010-04       Impact factor: 10.047

5.  Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome.

Authors:  Jianbing Mu; Philip Awadalla; Junhui Duan; Kate M McGee; Jon Keebler; Karl Seydel; Gilean A T McVean; Xin-zhuan Su
Journal:  Nat Genet       Date:  2006-12-10       Impact factor: 38.330

6.  Protein synthesis in vitro by cryopreserved Plasmodium falciparum.

Authors:  C Diggs; K Joseph; B Flemmings; R Snodgrass; F Hines
Journal:  Am J Trop Med Hyg       Date:  1975-09       Impact factor: 2.345

7.  Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project.

Authors:  Z Zhou; L Xiao; O H Branch; S Kariuki; B L Nahlen; A A Lal
Journal:  Am J Trop Med Hyg       Date:  2002-01       Impact factor: 2.345

8.  Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19).

Authors:  N Ahlborg; I T Ling; A A Holder; E M Riley
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

9.  Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial.

Authors:  Mahamadou A Thera; Ogobara K Doumbo; Drissa Coulibaly; Dapa A Diallo; Issaka Sagara; Alassane Dicko; David J Diemert; D Gray Heppner; V Ann Stewart; Evelina Angov; Lorraine Soisson; Amanda Leach; Kathryn Tucker; Kirsten E Lyke; Christopher V Plowe
Journal:  PLoS Clin Trials       Date:  2006-11-24

10.  Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children.

Authors:  Daniel Dodoo; Anastasia Aikins; Kwadwo Asamoah Kusi; Helena Lamptey; Ed Remarque; Paul Milligan; Samuel Bosomprah; Roma Chilengi; Yaa Difie Osei; Bartholomew Dicky Akanmori; Michael Theisen
Journal:  Malar J       Date:  2008-07-29       Impact factor: 2.979

View more
  8 in total

1.  A Malaria-Resistant Phenotype with Immunological Correlates in a Tanzanian Birth Cohort Exposed to Intense Malaria Transmission.

Authors:  Scott D Nash; D Rebecca Prevots; Edward Kabyemela; Yogender P Khasa; Kun-Lin Lee; Michal Fried; Patrick E Duffy
Journal:  Am J Trop Med Hyg       Date:  2017-05       Impact factor: 2.345

2.  Exclusive Breastfeeding and Clinical Malaria Risk in 6-Month-Old Infants: A Cross-Sectional Study from Kinshasa, Democratic Republic of the Congo.

Authors:  Nicholas F Brazeau; Martine Tabala; Landry Kiketa; Dyna Kayembe; Jean Lambert Chalachala; Bienvenu Kawende; Bruno Lapika; Steven R Meshnick; Marcel Yotebieng
Journal:  Am J Trop Med Hyg       Date:  2016-08-22       Impact factor: 2.345

3.  Maternally-derived Antibodies to Schizont Egress Antigen-1 and Protection of Infants From Severe Malaria.

Authors:  Jonathan D Kurtis; Dipak K Raj; Ian C Michelow; Sangshin Park; Christina E Nixon; Emily A McDonald; Christian P Nixon; Sunthorn Pond-Tor; Ambrish Jha; Ross J Taliano; Edward R Kabyemela; Jennifer F Friedman; Patrick E Duffy; Michal Fried
Journal:  Clin Infect Dis       Date:  2019-05-02       Impact factor: 9.079

4.  Maternal-foetal transfer of Plasmodium falciparum and Plasmodium vivax antibodies in a low transmission setting.

Authors:  Sarah C Charnaud; Rose McGready; Asha Herten-Crabb; Rosanna Powell; Andrew Guy; Christine Langer; Jack S Richards; Paul R Gilson; Kesinee Chotivanich; Takafumi Tsuboi; David L Narum; Mupawjay Pimanpanarak; Julie A Simpson; James G Beeson; François Nosten; Freya J I Fowkes
Journal:  Sci Rep       Date:  2016-02-10       Impact factor: 4.379

5.  Placental Malaria: Decreased Transfer of Maternal Antibodies Directed to Plasmodium falciparum and Impact on the Incidence of Febrile Infections in Infants.

Authors:  Celia Dechavanne; Gilles Cottrell; André Garcia; Florence Migot-Nabias
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

Review 6.  Plasmodium malaria and antimalarial antibodies in the first year of life.

Authors:  Katherine R Dobbs; Arlene E Dent
Journal:  Parasitology       Date:  2016-01-08       Impact factor: 3.234

7.  Prenatal exposure to Plasmodium falciparum increases frequency and shortens time from birth to first clinical malaria episodes during the first two years of life: prospective birth cohort study.

Authors:  Boniphace Sylvester; Dinah B Gasarasi; Said Aboud; Donath Tarimo; Siriel Massawe; Rose Mpembeni; Gote Swedberg
Journal:  Malar J       Date:  2016-07-22       Impact factor: 2.979

8.  Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth Cohort.

Authors:  Arlene E Dent; Indu Malhotra; Xuelie Wang; Denise Babineau; Kee Thai Yeo; Timothy Anderson; Rhonda J Kimmel; Evelina Angov; David E Lanar; David Narum; Sheetij Dutta; Jack Richards; James G Beeson; Brendan S Crabb; Alan F Cowman; Toshihiro Horii; Eric Muchiri; Peter L Mungai; Christopher L King; James W Kazura
Journal:  Clin Vaccine Immunol       Date:  2015-12-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.